SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hind Bio Science - Quaterly Results

04 Feb 2022 Evaluate
A slight decline in the revenue of Rs. 2.40 millions was seen for the December 2021 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended December 2021 is Rs. -0.01 millions as compared to Net Loss of Rs. -1.14 millions of corresponding quarter ended December 2020 Operating profit Margin for the quarter ended December 2021 improved to 0.01% as compared to -1.08% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 2.40 0.00 0.00 4.34 8.82 -50.79 10.32 19.43 -46.89
Other Income 0.00 0.00 0.00 0.52 0.00 0.00 0.00 0.00 0.00
PBIDT 0.01 -1.08 -100.93 -1.26 -0.23 447.83 -9.39 1.35 -795.56
Interest 0.01 0.04 -75.00 0.03 0.07 -57.14 0.07 0.08 -12.50
PBDT 0.00 -1.12 -100.00 -1.29 -0.30 330.00 -9.46 1.27 -844.88
Depreciation 0.01 0.02 -50.00 0.03 0.06 -50.00 0.08 0.11 -27.27
PBT -0.01 -1.14 -99.12 -1.32 -0.36 266.67 -9.54 1.16 -922.41
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -0.16 0.35 -145.71
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.17 -94.12
PAT -0.01 -1.14 -99.12 -1.32 -0.36 266.67 -9.38 0.81 -1258.02
Equity 102.81 102.51 0.29 102.81 102.51 0.29 102.51 102.51 0.00
PBIDTM(%) 0.42 0.00 0.00 -29.03 -2.61 1013.33 -90.99 6.95 -1409.56

Hind Bio Science Share Price

9.24 0.44 (5.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×